Skip to content

The effect of Botox on chronic pelvic pain and sexual satisfaction in women with endometriosis

Comparison of chronic pelvic pain and sexual satisfaction in women with endometriosis in two groups with and without botulinum toxin injection

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002576N20
Enrollment
32
Registered
2021-07-02
Start date
2021-09-23
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Endometriosis, unspecified

Interventions

Intervention 1: Intervention group: After a vaginal digital examination to identify pelvic muscles with spasms, and 20 to 30 minutes before the start of the intervention, up to 10 mg of oral diazepam

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 18-50 years Chronic pelvic pain for at least 3 months Do not start new analgesic strategies since one month before the intervention

Exclusion criteria

Exclusion criteria: The primary cause of chronic pelvic pain is the following: infection, gastrointestinal or psychological disorder, fibromyalgia, chronic fatigue syndrome Severe untreated cervical dysplasia History of hysterectomy and bilateral salpingo-oophorectomy Allergy to botulinum toxin Pregnancy or breastfeeding History of urinary and fecal incontinence Known pelvic prolapse Neuromuscular disorders such as myasthenia gravis or Lambert Aton syndrome

Design outcomes

Primary

MeasureTime frame
Chronic pelvic pain. Timepoint: Twice, before the intervention and one month after the intervention. Method of measurement: Visual Analog Scale (VAS Ruler).

Secondary

MeasureTime frame
Sexual satisfaction rate. Timepoint: Once, at the end of the study. Method of measurement: Female Sexual Function Index Scoring.;Dysmenorrhea. Timepoint: Twice, before the intervention and one month after the intervention. Method of measurement: Visual Analog Scale (VAS Ruler).;Dyspareunia. Timepoint: Twice, before the intervention and one month after the intervention. Method of measurement: Visual Analog Scale (VAS Ruler).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fdavaritanha@sina.tums.ac.ir+98 21 8831 3955

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026